Kevin E. Weddington

Array ( [id] => 112735 [patent_doc_number] => 07713964 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-05-11 [patent_title] => 'Methods for treating asthmatic conditions' [patent_app_type] => utility [patent_app_number] => 10/302171 [patent_app_country] => US [patent_app_date] => 2002-11-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 69257 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/713/07713964.pdf [firstpage_image] =>[orig_patent_app_number] => 10302171 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6711671 [patent_doc_number] => 20030171420 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-11 [patent_title] => 'Compounds and compositions for use in ingibting endoparasitic fatty acid biosynthesis' [patent_app_type] => new [patent_app_number] => 10/169601 [patent_app_country] => US [patent_app_date] => 2002-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3957 [patent_no_of_claims] => 55 [patent_no_of_ind_claims] => 23 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0171/20030171420.pdf [firstpage_image] =>[orig_patent_app_number] => 10169601 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6684002 [patent_doc_number] => 20030119866 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-26 [patent_title] => 'Methods of use of fluoroquinolone compounds against maxillary sinus pathogenic bacteria' [patent_app_type] => new [patent_app_number] => 10/300407 [patent_app_country] => US [patent_app_date] => 2002-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3734 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0119/20030119866.pdf [firstpage_image] =>[orig_patent_app_number] => 10300407 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1139154 [patent_doc_number] => 06780890 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-08-24 [patent_title] => 'Compounds and methods for regulating bacterial growth and pathogenesis' [patent_app_type] => B2 [patent_app_number] => 10/300818 [patent_app_country] => US [patent_app_date] => 2002-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 38 [patent_figures_cnt] => 56 [patent_no_of_words] => 38870 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/780/06780890.pdf [firstpage_image] =>[orig_patent_app_number] => 10300818 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6658357 [patent_doc_number] => 20030078303 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-04-24 [patent_title] => 'Methods of treating and preventing sexual dysfunction using (+) sibutramine in combination with phosphodiesterase inhibitors' [patent_app_type] => new [patent_app_number] => 10/295871 [patent_app_country] => US [patent_app_date] => 2002-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11419 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0078/20030078303.pdf [firstpage_image] =>[orig_patent_app_number] => 10295871 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7368495 [patent_doc_number] => 20040092592 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-13 [patent_title] => 'Stabilized L-Arginine platelet aggregation inhibitory compositions and processes for making same' [patent_app_type] => new [patent_app_number] => 10/291283 [patent_app_country] => US [patent_app_date] => 2002-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4210 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0092/20040092592.pdf [firstpage_image] =>[orig_patent_app_number] => 10291283 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1209854 [patent_doc_number] => 06713500 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-03-30 [patent_title] => 'Agent for controlling animal diseases caused by parasites' [patent_app_type] => B2 [patent_app_number] => 10/289257 [patent_app_country] => US [patent_app_date] => 2002-11-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3916 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 503 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/713/06713500.pdf [firstpage_image] =>[orig_patent_app_number] => 10289257 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6814095 [patent_doc_number] => 20030073645 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-04-17 [patent_title] => 'Treatment of diabetes with thiazolidinedione and alpha-glucosidase inhibitor' [patent_app_type] => new [patent_app_number] => 10/290132 [patent_app_country] => US [patent_app_date] => 2002-11-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3577 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0073/20030073645.pdf [firstpage_image] =>[orig_patent_app_number] => 10290132 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7404485 [patent_doc_number] => 20040023989 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-05 [patent_title] => 'Treatment of insulin resistance syndrome and type 2 diabetes with PDE9 inhibitors' [patent_app_type] => new [patent_app_number] => 10/283814 [patent_app_country] => US [patent_app_date] => 2002-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27134 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0023/20040023989.pdf [firstpage_image] =>[orig_patent_app_number] => 10283814 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7237707 [patent_doc_number] => 20050080026 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-04-14 [patent_title] => 'Mnk kinase homologous proteins involved in the regulation of energy homeostasis and organelle metabolism' [patent_app_type] => utility [patent_app_number] => 10/494010 [patent_app_country] => US [patent_app_date] => 2002-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 35 [patent_no_of_words] => 23815 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0080/20050080026.pdf [firstpage_image] =>[orig_patent_app_number] => 10494010 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6805399 [patent_doc_number] => 20030232793 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-12-18 [patent_title] => 'Use of creatine analogues and creatine kinase modulators for the prevention and treatment of glucose metabolic disorders' [patent_app_type] => new [patent_app_number] => 10/281379 [patent_app_country] => US [patent_app_date] => 2002-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 9193 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0232/20030232793.pdf [firstpage_image] =>[orig_patent_app_number] => 10281379 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6683885 [patent_doc_number] => 20030119749 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-26 [patent_title] => 'Novel compounds possessing antibacterial, antifungal or antitumor activity' [patent_app_type] => new [patent_app_number] => 10/277666 [patent_app_country] => US [patent_app_date] => 2002-10-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 37249 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0119/20030119749.pdf [firstpage_image] =>[orig_patent_app_number] => 10277666 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6739779 [patent_doc_number] => 20030157148 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-08-21 [patent_title] => 'Methods for inhibiting the production of TSST-1' [patent_app_type] => new [patent_app_number] => 10/271474 [patent_app_country] => US [patent_app_date] => 2002-10-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10111 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0157/20030157148.pdf [firstpage_image] =>[orig_patent_app_number] => 10271474 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6801694 [patent_doc_number] => 20030096859 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-22 [patent_title] => 'Methods for protecting cells from amyloid toxicity and for inhibiting amyloid protein production' [patent_app_type] => new [patent_app_number] => 10/269477 [patent_app_country] => US [patent_app_date] => 2002-10-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9741 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0096/20030096859.pdf [firstpage_image] =>[orig_patent_app_number] => 10269477 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6852042 [patent_doc_number] => 20030144245 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-31 [patent_title] => 'Medical and nutritional applications of highly refined cellulose' [patent_app_type] => new [patent_app_number] => 10/270475 [patent_app_country] => US [patent_app_date] => 2002-10-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 24582 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0144/20030144245.pdf [firstpage_image] =>[orig_patent_app_number] => 10270475 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6678996 [patent_doc_number] => 20030229137 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-12-11 [patent_title] => 'Methods of inhibiting osteoclast activity' [patent_app_type] => new [patent_app_number] => 10/269722 [patent_app_country] => US [patent_app_date] => 2002-10-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5102 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0229/20030229137.pdf [firstpage_image] =>[orig_patent_app_number] => 10269722 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6669404 [patent_doc_number] => 20030114388 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-19 [patent_title] => 'Auxiliary agents for ophthalmic operation' [patent_app_type] => new [patent_app_number] => 10/182441 [patent_app_country] => US [patent_app_date] => 2002-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2196 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0114/20030114388.pdf [firstpage_image] =>[orig_patent_app_number] => 10182441 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 963717 [patent_doc_number] => 06949529 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-09-27 [patent_title] => 'Compositions containing lysophosphotidic acids which inhibit apoptosis and uses thereof' [patent_app_type] => utility [patent_app_number] => 10/267568 [patent_app_country] => US [patent_app_date] => 2002-10-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 32 [patent_no_of_words] => 44440 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/949/06949529.pdf [firstpage_image] =>[orig_patent_app_number] => 10267568 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6674886 [patent_doc_number] => 20030060489 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-03-27 [patent_title] => 'Novel method of treatment' [patent_app_type] => new [patent_app_number] => 10/168872 [patent_app_country] => US [patent_app_date] => 2002-10-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3507 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0060/20030060489.pdf [firstpage_image] =>[orig_patent_app_number] => 10168872 [rel_patent_id] =>[rel_patent_doc_number] =>)